Roche (OTCMKTS:RHHVF) Shares Down 1.8% – Here’s Why

Roche Holding AG (OTCMKTS:RHHVF)’s stock price dropped 1.8% on Tuesday . The stock traded as low as $402.14 and last traded at $402.14. Approximately 321 shares changed hands during trading, a decline of 97% from the average daily volume of 9,266 shares. The stock had previously closed at $409.6960.

Roche Stock Down 1.8%

The business’s fifty day moving average is $374.99 and its 200 day moving average is $345.33.

Roche Company Profile

Roche Holding AG, traded on the OTCMKTS under the symbol RHHVF, is a leading global healthcare company with two core business divisions: Pharmaceuticals and Diagnostics. The company focuses on developing innovative medicines and diagnostic tests that address serious diseases, driving advances in personalized healthcare and precision medicine.

In its Pharmaceuticals division, Roche pioneers targeted therapies across oncology, immunology, ophthalmology and neuroscience. Flagship products include monoclonal antibodies and small-molecule treatments such as Herceptin, Avastin and Actemra, which have become standards of care for cancer and autoimmune conditions.